Efficacy and Safety of Gemigliptin Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone

被引:0
|
作者
Rhee, Eun Jung
Min, Kyung Wan
Jang, Hak Chul
Nam-Goong, Il Seong
Chung, Choon Hee
Park, Joong Yeol
Bae, Hak Yeon
Kim, Doo-Man
Baik, Sei Hyun
Lee, Moon-Kyu
Kim, Byung-Joon
Chang, Sang Ah
Ahn, Chul Woo
Kim, Yong Seong
Yoon, Kun Ho
Park, Kyong Soo
Kim, Hae Jin
Shivane, Vyankatesh K.
Sosale, Aravind R.
Dharmalingam, Mala
Gandhi, Pramod
Gupta, Sandeep Kumar
Pitale, Shailesh
Agarwal, Pankaj Kumar
Rais, Nadeem
Mohan, V.
Mahesh, Uma
Kim, Jeong Ae
Kim, Pan Kyung
Kim, Sun Woo
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1128-P
引用
收藏
页码:A291 / A291
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Rhee, E. J.
    Min, K. W.
    Jang, H. C.
    Chung, C. H.
    Nam-Goong, I. S.
    Bae, H. Y.
    Lee, M. K.
    Baik, S. H.
    Shivane, V. K.
    Sosale, A. R.
    Dharmalingam, M.
    Gandhi, P.
    Gupta, S. K.
    Kim, J. A.
    Kim, S. W.
    [J]. DIABETOLOGIA, 2012, 55 : S352 - S352
  • [2] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Rhee, E. J.
    Lee, W. Y.
    Min, K. W.
    Shivane, V. K.
    Sosale, A. R.
    Jang, H. C.
    Chung, C. H.
    Nam-Goong, I. S.
    Kim, J. A.
    Kim, S. W.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (06): : 523 - 530
  • [3] Efficacy and safety of sitagliptin added to ongoing metformin therapy in type 2 diabetes patients who were inadequately controlled on metformin alone
    Meininger, G.
    Charbonnel, B.
    Karasik, A.
    Liu, J.
    Wu, M.
    Meehan, A.
    [J]. DIABETOLOGIA, 2006, 49 : 5 - 6
  • [4] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Charbonnel, Bernard
    Karasik, Avraham
    Liu, Ji
    Wu, Mei
    Meininger, Gary
    [J]. DIABETES CARE, 2006, 29 (12) : 2638 - 2643
  • [5] The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
    DeFronzo, Ralph A.
    Hissa, Miguel N.
    Garber, Alan J.
    Gross, Jorge Luiz
    Duan, Raina Yuyan
    Ravichandran, Shoba
    Chen, Roland S.
    [J]. DIABETES CARE, 2009, 32 (09) : 1649 - 1655
  • [6] Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
    Raz, Itamar
    Chen, Yu
    Wu, Mei
    Hussain, Shehla
    Kaufman, Keith D.
    Amatruda, John M.
    Langdon, Ronald B.
    Stein, Peter P.
    Alba, Maria
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 537 - 550
  • [7] Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes
    Scott, R.
    Loeys, T.
    Davies, M. J.
    Engel, S. S.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (10): : 959 - 969
  • [8] Efficacy and safety of sitagliptin or rosiglitazone when added to ongoing metformin therapy in patients with Type 2 diabetes
    Scott, Russell
    Loeys, Tom
    Davies, Michael J.
    Engel, Samuel S.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S32 - S32
  • [9] Efficacy and Safety of Gemigliptin as Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on Metformin and Glimepiride
    Han, Kyung Ah
    Yu, Jae Myung
    Jang, Hak Chul
    Ahn, Kyu Jeung
    Oh, Takkeun
    Lee, Hyoung Woo
    Lee, Daeho
    Kim, Jae Taek
    Park, Tae Sun
    Nam, Joo Young
    Chung, Choon Hee
    Kim, Byung-Joon
    Park, Seok Won
    Kim, Sung-Ho
    Park, Kyong Soo
    [J]. DIABETES, 2016, 65 : A307 - A307
  • [10] Efficacy and safety of gemigliptin as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and glimepiride
    Kim, S. -H.
    Yu, J.
    Jang, H.
    Song, Y.
    Ahn, K.
    Oh, T.
    Lee, H.
    Lee, D.
    Kim, J.
    Park, T. -S.
    Jeong, C. -H.
    Kim, B. -J.
    Han, K.
    Park, K.
    [J]. DIABETOLOGIA, 2016, 59 : S357 - S357